Article Data

  • Views 328
  • Dowloads 136

Original Research

Open Access

Characteristics and prognosis of ovarian metastatic tumors: review of a single-institution experience

  • V. Ulker1,*,
  • C. Numanoglu1
  • V. Alpay2
  • O. Akbayir1
  • I. Polat2
  • A. Gedikbasi2
  • A. Akca2

1Department of Obstetrics and Gynecology, Oncology Unit, Bakirkoy Woman and Children Training and Research Hospital, Istanbul

2Department of Obstetrics and Gynecology, Bakirkoy Woman and Children Training and Research Hospital, Istanbul (Turkey).

DOI: 10.12892/ejgo340114 Vol.34,Issue 1,January 2013 pp.75-78

Published: 10 January 2013

*Corresponding Author(s): V. Ulker E-mail:


Background: To evaluate the clinico-pathological characteristics and role of surgery in patients with ovarian metastasis. Materials and Methods: Clinical data from 51 patients with pathologically confirmed ovarian metastasis were reviewed. Results: Ovarian metastasis accounted for 14% of all malignant ovarian neoplasms (51/364). Of the 51 metastatic ovarian tumor cases, 24 originated from gynecologic malignancies, while 27 originated from non-gynecologic malignancies. Optimal cytoreduction was performed in 88% and 37% of patients with metastases of gynecologic and non-gynecologic origin, respectively. Patients with ovarian metastasis had a two-year survival rate in 82% of the gynecologic group and 70% of the non-gynecologic group (p = 0.35). The five-year survival rate of patients with non-gynecologic tumor origin (29%) was significantly worse (p = 0.04) than the survival rates of those with tumors of gynecologic origin (61%). In the non-gynecologic group, the five-year survival rates were significantly different between patients who were performed optimal cytoreductive surgery vs those without this procedure (42% and 20%, respectively; p = 0.04). Conclusion: Although complete surgical resection is not achievable in approximately two-thirds of patients with metastases of non-gynecological origin, optimal tumor cytoreduction appears to improve survival, which is statistically significant in all patients with ovarian metastatic tumors.


Ovarian metastasis; Cytoreductive surgery; Krukenberg tumor.

Cite and Share

V. Ulker,C. Numanoglu, V. Alpay,O. Akbayir,I. Polat,A. Gedikbasi, A. Akca. Characteristics and prognosis of ovarian metastatic tumors: review of a single-institution experience. European Journal of Gynaecological Oncology. 2013. 34(1);75-78.


[1] Yada-Hashimoto N., Yamamoto T., Kamiura S., Seino H., Ohira H., Sawai K. et al.: “Metastatic ovarian tumors: a review of 64 cases”. Gynecol. Oncol., 2003, 89, 314.

[2] Ulbright T.M., Roth L.M., Stehman F.B.: “Secondary ovarian neoplasia: a clinicopathologic study of 35 cases”. Cancer, 1984, 53, 1164.

[3] Santesson L., Kottmeier H.L.: “General classification of ovarian tumours”. In: Gentil F., Junqueira A.C. (eds.). Ovarian cancer. UICC monograph series, vol. 11. Berlin’ Springer-Verlag, 1968, 1.

[4] Petru E., Pickel H., Heydarfadai M., Lahousen M., Haas J., Schaider H. et al.: “Nongenital cancers metastatic to the ovary”. Gynecol. Oncol., 1992, 44, 83.

[5] Ayhan A., Guvenal T., Salman M.C., Ozyuncu O., Sakinci M., Basaran M.: “The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries”. Gynecol. Oncol., 2005, 98, 235.

[6] Kim W.Y., Kim T.J., Kim S.E., Lee J.W., Lee J.H., Kim B.G., Bae D.S.: “The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2010, 149, 97.

[7] Young R.H., Scully R.E.: “Differential diagnosis of ovarian tumors based primarily on their patterns and cell types”. Semin. Diagn. Pathol., 2001, 18, 161.

[8] Webb M.J., Decker D.G., Mussey E.: “Cancer metastatic to the ovary: factors influencing survival”. Obstet. Gynecol., 1975, 45, 391.

[9] Fujiwara K., Ohishi Y., Koike H., Sawada S., Moriya T., Kohno I.: “Clinical implications of metastases to the ovary”. Gynecol. Oncol., 1995, 59, 124.

[10] Miller B.E., Pittman B., Wan J.Y., Fleming M.: “Colon cancer with metastasis to the ovary at time of initial diagnosis”. Gynecol. Oncol., 1997, 66, 368.

[11] Lee S.J., Bae J.H., Lee A.W., Tong S.Y., Park Y.G., Park S.J.: “Clinical characteristics of metastatic tumors to the ovaries”. J. Korean Med. Sci., 2009, 24, 114.

[12] Woodruff J.D., Novak E.R.: “The Krukenberg tumor: study of 48 cases from the ovarian tumor registry”. Obstet. Gynecol., 1960, 15, 351.

[13] Yong-Jung Song B.G.K., Sang-Young R.: “Clinicopathologic characteristics of 42 cases of Krukenberg tumor of the ovary. Korean J. Obstet. Gynecol., 2001, 44, 2243.

[14] Cheong J.H., Hyung W.J., Chen J., Kim J., Choi S.H., Noh S.H.: “Surgical management and outcome of metachronous Krukenberg tumors from gastric cancer”. J. Surg. Oncol., 2004, 87, 39.

[15] Hunter J.A., Ryan J.A., Schultz P.: “En bloc resection of colon cancer adherent to other organs”. Am. J. Surg., 1987, 154, 67.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time